Guggenheim Capital LLC Veru Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.64 - $2.29 $17,447 - $24,363	-10,639 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$1.19 - $2.17 $528 - $963	-444 Reduced 4.01%	10,639 $19,000
Q4 2017 Feb 14, 2018	SELL	$0.98 - $2.27 $1,356 - $3,141	-1,384 Reduced 11.1%	11,083 $13,000
Q3 2017 Nov 14, 2017	BUY	$1.2 - $2.84 $14,960 - $35,406	12,467	12,467 $33,000

115

58M

539K

367K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $62.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.